US Patent Issued to NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY on Sept. 15 for "Cancer biomarker in pancreatic cancer or malignant intraductal papillary mucinous neoplasm" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,736,536, issued on Sept. 15, was assigned to NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (Gunma, Japan).

"Cancer biomarker in pancreatic cancer or malignant intraductal papillary mucinous neoplasm" was invented by Shin Yazawa (Gunma, Japan), Norio Kubo (Gunma, Japan) and Ken Shirabe (Gunma, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Fucosylated Alpha1-acid glycoprotein (fAGP) was found to be useful for the diagnosis of pancreatic cancer and malignant intraductal papillary mucinous neoplasm (IPMC), resulting in the finding of a new biomarker for pancreatic cancer or malignant intraductal papillary mucinous neoplasm (IPMC), in particular, ...